Neurocrine Biosciences (NBIX) EBT Margin Growth (3y) (2013 - 2026)
Neurocrine Biosciences (NBIX) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1,840.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -134.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1,686.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 12,811.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 5,487.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -225.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -15,283.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1,162.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 4,514.00 |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 25,271.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,487.00 |
| Dec 31, 2025 | 110.00 |
| Sep 30, 2025 | 1,147.00 |
| Jun 30, 2025 | 13,970.00 |
| Mar 31, 2025 | -432.00 |
| Dec 31, 2024 | 3,033.00 |
| Sep 30, 2024 | 2,029.00 |
| Jun 30, 2024 | -320.00 |
| Mar 31, 2024 | -480.00 |
| Dec 31, 2023 | 2,165.00 |
| Sep 30, 2023 | 4,526.00 |
| Jun 30, 2023 | -65.00 |
| Mar 31, 2023 | -4,098.00 |
| Dec 31, 2022 | 1,280.00 |
| Sep 30, 2022 | -106.00 |
| Jun 30, 2022 | -14,489.00 |
| Mar 31, 2022 | 8,102.00 |
| Dec 31, 2021 | -1,870.00 |
| Sep 30, 2021 | -2,315.00 |
| Jun 30, 2021 | 2,600.00 |